While Crohn’s disease is a lifelong condition, it doesn’t have to define your life. It can be managed with medication, mental ...

However, for practical purposes, rectal involvement is frequently considered part of anoperineal disease. Traditionally, the treatment of patients with Crohn's disease has focused on decreasing ...

Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, ...

Dysphagia, or difficulty swallowing, is one such symptom that can be particularly alarming. Here’s what you can do if you ...

Constipation in Crohn’s disease may be caused by lifestyle and dietary factors, as well as medical conditions like strictures. Treatment may include eating more fiber, taking laxatives ...

Researchers believe these findings may pave the way for new treatments for Crohn’s disease as medications are mainly limited to alleviating the symptoms of the disease. “The big hope is to ...

driving the development of Crohn's disease, new research in mice suggests. If these findings hold true in humans, they could ultimately lead to the development of targeted treatments that get at ...

Research shows that people with IBD are twice as likely to have anxiety or depression as the general population. While the ...

P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...

Researchers will study the role the gut microbiome plays in post-operative outcomes for patients with Crohn’s disease.

Potential for new Crohn’s disease treatments Researchers believe these findings may pave the way for new treatments for Crohn’s disease as medications are mainly limited to alleviating the ...